Choriocarcinoma

• CLINICAL_TRIALS trial_result · 2025-01-13
  Clinical Trial Update: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors [Phase 3]

  This entry describes a Phase 3 trial comparing standard-dose versus high-dose combination chemotherapy with stem cell transplant for relapse…

• CLINICAL_TRIALS trial_result · 2019-08-13
  Clinical Trial Update: Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia [Phase 3]

  Phase 3 trial evaluating dactinomycin or methotrexate for low-risk gestational trophoblastic neoplasia has completed with results posted.

• CLINICAL_TRIALS trial_result · 2019-06-11
  Clinical Trial Update: TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma [Phase 2]

  Phase 2 trial evaluating TRC105 with standard-dose bevacizumab in two patients with metastatic and refractory choriocarcinoma has completed;…

• CLINICAL_TRIALS trial_result · 2019-06-04
  Clinical Trial Update: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) [Phase 2]

  Phase 2 trial of TRC105 with bevacizumab in refractory gestational trophoblastic neoplasia terminated; results posted in 2019.

• CLINICAL_TRIALS trial_result · 2007-08-09
  Clinical Trial Update: A Trial for Patients With Gestational Trophoblastic Disease [Phase 2]

  Phase 2 trial update for gestational trophoblastic disease reports completion of the study with conditions including trophoblastic neoplasms…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.